Cargando…

Multiple risks analysis for aplastic anemia in Zhejiang, China: A case-control study

To understand the risks associated with aplastic anemia (AA) in 4 cities of Zhejiang Province, China, with special focus on the joint contributions of multiple risks. Based on an Electronic Data Capture (EDC), a case control study was carried out. Data regarding socio-demographic, diseases history,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Li-qiang, Shen, Ying-ying, Zhang, Ying, Kuang, Yue-min, Fang, Bing-mu, Wang, Zhou-zheng, Fu, Li-juan, Shao, Ke-ding, Shen, Jian-ping, Zhou, Yu-hong, Shen, Yi-ping, Ye, Bao-dong, Zheng, Zhi-yin, Chen, Jun-fa, Lin, Sheng-yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408124/ https://www.ncbi.nlm.nih.gov/pubmed/30813154 http://dx.doi.org/10.1097/MD.0000000000014519

Ejemplares similares

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Perspective and Experience of Patients with Aplastic Anemia on Medication Adherence
por: Li, Hangting, et al.
Publicado: (2023)

Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review
por: Li, Yuzhu, et al.
Publicado: (2022)

Integrated Network Pharmacology and Metabolomics Analysis to Reveal the Potential Mechanism of Siwu Paste on Aplastic Anemia Induced by Chemotherapy Drugs
por: He, Dan, et al.
Publicado: (2022)

Hydrogen therapy may be an effective and specific novel treatment for aplastic anemia
por: Qian, Liren, et al.
Publicado: (2012)

Analysis of Continuous Nursing Intervention on Aplastic Anemia Patients Based on the “Information-Motivation-Behavioral Skills Model”
por: Shen, Wei, et al.
Publicado: (2021)

Recurrent ovarian hemorrhage in a patient with aplastic anemia: A case report
por: Yang, Hua-Di, et al.
Publicado: (2018)

Epimedium Polysaccharide Ameliorates Benzene-Induced Aplastic Anemia in Mice
por: He, Jin, et al.
Publicado: (2020)

PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia
por: Liu, Chunyan, et al.
Publicado: (2018)

Risk factors associated with poor response to immunosuppressive therapy in acquired aplastic anemia: A meta-analysis of retrospective studies
por: Wang, Jia, et al.
Publicado: (2020)

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia
por: Gao, Xuan, et al.
Publicado: (2022)

Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
por: Contejean, Adrien, et al.
Publicado: (2019)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study
por: Luo, Xiu, et al.
Publicado: (2018)

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study
por: Shen, Yingying, et al.
Publicado: (2023)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Epstein–Barr-virus-associated hepatitis with aplastic anemia: A case report
por: Zhang, Wan-Jun, et al.
Publicado: (2022)

Molecular alterations in the TCR signaling pathway in patients with aplastic anemia
por: Li, Bo, et al.
Publicado: (2016)

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
por: Huo, Jiali, et al.
Publicado: (2020)

Gut inflammation in the pathogenesis of acquired aplastic anemia
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study
por: Liu, Qi, et al.
Publicado: (2022)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

Osteonecrosis of the hip in patients with aplastic anemia.
por: Park, Jeongmi, et al.
Publicado: (2002)

Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010)

Ecthyma gangrenosum associated with aplastic anemia.
por: Chun, W. H., et al.
Publicado: (1996)

Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013)

Child with aplastic anemia: Anesthetic management
por: Kaur, Manpreet, et al.
Publicado: (2012)

Recent advances in treatment of aplastic anemia
por: Shin, Seung Hwan, et al.
Publicado: (2014)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

Aplastic Anemia in Triple X Syndrome
por: Aldarwish, Mohammed, et al.
Publicado: (2023)

Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
por: Peng, Guangxin, et al.
Publicado: (2022)

Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia
por: Sun, Yuan-xin, et al.
Publicado: (2016)

Abnormal miR-214/A20 expression might play a role in T cell activation in patients with aplastic anemia
por: Yu, Zhi, et al.
Publicado: (2020)

Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs
por: Jia, Wang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f5suint2g0n0rsvs3q7h4cj3t2